The purpose of this randomized, controlled study is to evaluate whether the knowledge of a personalized diabetes risk score affects adherence to a 12-week diet and exercise lifestyle change program in prediabetic patients. The intervention group will receive diabetes risk score results at the beginning of the twelve weeks, and the control group will not receive these results. Both groups will review their baseline and 12-week diabetes risk score results at the conclusion of the program and will be followed for an additional twelve weeks. Attendance rates and changes in weight, BMI, abdominal circumference, blood pressure, HgA1c, fasting blood glucose, cholesterol, and diabetes risk score will be compared between the groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
223
David Grant Medical Center
Travis AFB, California, United States
Andrews Military Medical Center
Andrews Air Force Base Census Designated Place, Maryland, United States
Nellis Family Medicine
Nellis Air Force Base, Nevada, United States
Wright Patterson Medical Center
Wright-Patterson AFB, Ohio, United States
Wilford Hall Ambulatory Surgical Center
Lackland Air Force Base, Texas, United States
Attendance rates
Attendance rates (percentage of subjects attending the classes) of the two groups will be compared.
Time frame: 6 months
Change in weight
change in weight from baseline to 12 weeks and 24 weeks will be compared between groups.
Time frame: baseline, 12 weeks, 24 weeks
Change in BMI
change in BMI from baseline to 12 weeks and 24 weeks will be compared between groups.
Time frame: baseline, 12 weeks, 24 weeks
Change in abdominal circumference
change in abdominal circumference from baseline to 12 weeks and 24 weeks will be compared between groups.
Time frame: baseline, 12 weeks, 24 weeks
Change in blood pressure
change in blood pressure from baseline to 12 weeks and 24 weeks will be compared between groups.
Time frame: baseline, 12 weeks, 24 weeks
Change in HgA1c
change in HgA1c from baseline to 12 weeks and 24 weeks will be compared between groups.
Time frame: baseline, 12 weeks, 24 weeks
Change in fasting blood glucose
change in fasting blood glucose from baseline to 12 weeks and 24 weeks will be compared between groups.
Time frame: baseline, 12 weeks, 24 weeks
Change in cholesterol
change in cholesterol from baseline to 12 weeks and 24 weeks will be compared between groups.
Time frame: baseline, 12 weeks, 24 weeks
Change in diabetes risk score
change in diabetes risk score from baseline to 12 weeks and 24 weeks will be compared between groups.
Time frame: baseline, 12 weeks, and 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.